Lumican as a potential biomarker for diabetic nephropathy
Lumican is a potential biomarker for predicting DN and is closely related to the extracellular matrix. These findings provide novel insights into the clinical diagnosis and treatment of DN.
Authors
- Kai Wei (ORCID: https://orcid.org/0000-0001-7984-1758)
- Lijun Tang (ORCID: https://orcid.org/0000-0001-7563-994X)
- Yuejia Tao
- Zunsong Wang (ORCID: https://orcid.org/0000-0002-9771-6026)
- Shunyao Liu (ORCID: https://orcid.org/0000-0002-6500-7559)
- Ying Zhang (ORCID: https://orcid.org/0000-0001-9377-2365)
- Shanshan Zheng
- Ruixue Wang (ORCID: https://orcid.org/0009-0002-5428-4574)
- Yipeng Liu (ORCID: https://orcid.org/0000-0002-5672-1144)
Institutions
- Shandong Provincial QianFoShan Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Renal Failure
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1080/0886022x.2025.2480245
- Citations
- 4
- Primary Topic
- Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.37
Funders
- National Natural Science Foundation of China